[1]
L. L. Herbelin and R. L. Barohn, “Barriers to Clinica and Translational Research & Challengers of Investigator Initiated Multi-Center Clinical Trials”, merrill, pp. 15–24, Sep. 2015, doi: 10.17161/merrill.2015.7792.